A Colorado-based cannabis biotech firm announced Thursday that it has secured $10 million in private funding to accelerate production in California and Canada.
The company uses tissue-culture technology to make “plantlets” for both hemp and marijuana producers.
Front Range’s investors in the Series A round included Florida-based Phyto Partners and WelCan Capital of New York – both cannabis-focused venture capital funds – and Salveo Capital, an Illinois-based private equity fund.
Front Range also makes coffee rooting cuttings in California.
